Higher expression levels of the HOXA9 gene, closely associated with MLL-PTD and EZH2 mutations, predict inferior outcome in acute myeloid leukemia

Li Gao(China-Japan Friendship Hospital), Yi-Gai Ma(China-Japan Friendship Hospital), Hui Zhang(Chinese Academy of Medical Sciences & Peking Union Medical College), Fang Liu(Henan Provincial People's Hospital), Junzhong Sun(First Affiliated Hospital of Chinese PLA General Hospital)
OncoTargets and Therapy
February 1, 2016
10.2147/ott.s95279
Cited by 34

Related Papers

Epidemiology of Type 2 Diabetic Foot Problems and Predictive Factors for Amputation in China
|The International Journal of Lower Extremity Wounds|2015|153
Paclitaxel nanosuspension coated with P-gp inhibitory surfactants: II. Ability to reverse the drug-resistance of H460 human lung cancer cells
|Colloids and Surfaces B Biointerfaces|2014|37
TCF7 knockdown inhibits the imatinib resistance of chronic myeloid leukemia K562/G01 cells by neutralizing the Wnt/β‑catenin/TCF7/ABC transporter signaling axis
|Oncology Reports|2020|37
Lentivirus-mediated Bos taurus bta-miR-29b overexpression interferes with bovine viral diarrhoea virus replication and viral infection-related autophagy by directly targeting ATG14 and ATG9A in Madin–Darby bovine kidney cells
|Journal of General Virology|2014|25
Nilotinib Enhances the Efficacy of Conventional Chemotherapeutic Drugs in CD34+CD38− Stem Cells and ABC Transporter Overexpressing Leukemia Cells
|Molecules|2014|21